🔎 Trials Near Me

Hjem › Fedme › Arizona › Phoenix

Kliniske studier for Fedme i Phoenix, AZ

22 studier for Fedme søker deltakere på steder i og rundt Phoenix (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Early Tracking of Childhood Health Determinants (ETCHED) Study

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • NIDDK, Phoenix, Phoenix
1 Day – 99 Years · Alle kjønn · Oppdatert 28. sep. 2026 · NCT03481829

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • RIO Clinical Trials - Phoenix, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Synexus Clinical Research US, Inc., Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Elite Clinical Studies, LLC, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07353931

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

RekruttererFrivillige helsepersonell ønskes velkommen
  • NIDDK, Phoenix, Phoenix
Alder 18 til 99 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06223555

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 3
  • AURORA-1 Clinical Site, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekruttererFase 3
  • AURORA-2 Clinical Site, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RekruttererFase 3
  • HonorHealth, Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
Alder 18 til 99 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07037459

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RekruttererFase 2
  • Helios Clinical Research - Phoenix, Phoenix
Alder 18 til 75 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekruttererFase 3Frivillige helsepersonell ønskes velkommen
  • ACCOMPLISH-2 Research Site, Phoenix
Alder 18 til 79 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Synexus Clinical Research US, Inc., Phoenix
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07284979

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

RekruttererFrivillige helsepersonell ønskes velkommen
  • NIDDK, Phoenix, Phoenix
Alder 18 til 60 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05545306

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

RekruttererObservasjonsstudie
  • Exponent Phoenix, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07776678

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • Honor Health, Phoenix
  • Arizona Research Center, Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Phoenix
Alder 18 til 79 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07654361

Fibrosis Lessens After Metabolic Surgery

RekruttererFase 4Frivillige helsepersonell ønskes velkommen
  • Banner Health Center, Phoenix
Alder 18 til 75 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06374875

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

RekruttererFase 3
  • Arizona Research Center, Inc., Phoenix
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jul. 2026 · NCT07481630

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

RekruttererFase 3
  • The University of Arizona College of Medicine- Phoenix, Phoenix
Alder 18 til 75 · Alle kjønn · Oppdatert 14. nov. 2025 · NCT06499857

Fedme-studier i andre byer

Andre studier i Phoenix

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.